1. Home
  2. BLKB vs DRTS Comparison

BLKB vs DRTS Comparison

Compare BLKB & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackbaud Inc.

BLKB

Blackbaud Inc.

N/A

Current Price

$49.04

Market Cap

1.5B

Sector

Technology

ML Signal

N/A

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

N/A

Current Price

$11.33

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLKB
DRTS
Founded
1981
2015
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
BLKB
DRTS
Price
$49.04
$11.33
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
★ $56.25
$20.60
AVG Volume (30 Days)
362.5K
★ 534.2K
Earning Date
10-28-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 142.32
N/A
EPS
★ 2.49
N/A
Revenue
N/A
N/A
Revenue This Year
$4.30
N/A
Revenue Next Year
$4.68
$2,043.98
P/E Ratio
$20.64
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.58
$3.43
52 Week High
$64.84
$15.79

Technical Indicators

Market Signals
Indicator
BLKB
DRTS
Relative Strength Index (RSI) 38.59 32.73
Support Level $45.72 $6.68
Resistance Level $50.76 $11.48
Average True Range (ATR) 1.71 0.83
MACD -0.88 -0.20
Stochastic Oscillator 0.00 8.38

Price Performance

Historical Comparison
BLKB
DRTS

About BLKB Blackbaud Inc.

Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: